Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Marksans Pharma Limited
MARKSANSCurrent price
308.3 INR
+2.6 INR (+0.85%)
Last closed
305.7 INR
Company
marksanspharma.com
ISIN
INE750C01026
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
National Stock Exchange of India
Capitalization
138 532 241 427 INR
Yield for 12 month
+119.04 %
1Y
3Y
5Y
10Y
15Y
MARKSANS
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India. Address: Grandeur, Mumbai, India, 400053
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 617.34 INRP/E ratio
40.8144Dividend Yield
0.2 %Current Year
+21 774 069 999 INR
Last Year
+18 521 389 968 INR
Current Quarter
+5 906 179 974 INR
Last Quarter
+5 600 130 039 INR
Current Year
+7 713 749 968 INR
Last Year
+9 307 809 984 INR
Current Quarter
+2 279 100 018 INR
Last Quarter
+1 893 869 959 INR
Key Figures MARKSANS
1 year
3 years
5 years
10 years
EBITDA
4 886 792 703 INR
Operating Margin TTM
PE Ratio
40.8144
Return On Assets TTM
9.86 %
PEG Ratio
–
Return On Equity TTM
16.35 %
Wall Street Target Price
2 617.34 INR
Revenue TTM
22 679 920 640 INR
Book Value
45.57 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
18.1 %
Dividend Yield
0.2 %
Gross Profit TTM
9 120 460 000 INR
Earnings per share
7.49 INR
Diluted Eps TTM
7.49 INR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
28.9 %
Profit Margin
14.72 %
Dividend Analytics MARKSANS
Dividend growth over 5 years
900 %Continuous growth
1 yearPayout Ratio 5 years average
5 %Dividend History MARKSANS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.6
Ex Dividend Date
17.09.2024
Forward Annual Dividend Yield
0.21 %
Last Split Factor
10:1
Payout Ratio
–
Last Split Date
11.03.2008
Dividend Date
–
Stock Valuation MARKSANS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
40.8144
Forward PE
–
Enterprise Value Revenue
6.1618
Price Sales TTM
6.1601
Enterprise Value EBITDA
26.3204
Price Book MRQ
6.7084
Financials MARKSANS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MARKSANS
For 52 weeks
129.73 INR
328.8 INR
50 Day MA
287.24 INR
Shares Short Prior Month
–
200 Day MA
201.48 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart